Home > Income Statement > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Revenue

    Back to Income Statement
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

OXYGENTA PHARMACEUTICAL Last 5 Year Revenue History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹40 Cr₹31 Cr₹6,052,481 Cr₹52 Cr₹14 Cr

What is the latest Revenue of OXYGENTA PHARMACEUTICAL ?

The latest Revenue ratio of OXYGENTA PHARMACEUTICAL is ₹40 Cr based on Mar2025 Standalone results.
Year Revenue
Mar2025₹40 Cr
Mar2024₹31 Cr
Mar2023₹6,052,481 Cr
Mar2022₹52 Cr
Mar2021₹14 Cr

How is Revenue of OXYGENTA PHARMACEUTICAL Trending?

Years Revenue % Change
Mar2025 ₹40 Cr
27.93
Mar2024 ₹31 Cr
-100.00
Mar2023 ₹6,052,481 Cr
11,633,245.46
Mar2022 ₹52 Cr
279.32
Mar2021 ₹14 Cr -

Compare Revenue of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹225.8 Cr -2.7% 9% -19.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,847.0 Cr 6.8% -1.5% -2.4% Stock Analytics
DIVIS LABORATORIES ₹160,745.0 Cr 0% -4.8% 8.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,346.0 Cr 1.7% 4.1% 20.5% Stock Analytics
CIPLA ₹107,075.0 Cr 0.1% -12.8% -9.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,507.0 Cr 1.8% -0.7% 3.4% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-2.7%

9%

-19.6%

SENSEX

1.5%

-2.3%

9.5%


You may also like the below Video Courses